UBS analyst Mauricio Serna raised the firm’s price target on Dillard’s (DDS) to $460 from $184 and keeps a Sell rating on the shares. The firm updated the company’s model post the Q3 report. Dillard’s “is adept to drive modest sales growth,” the analyst tells investors in a research note. However, UBS sees “very limited” earnings growth potential for Dillard’s given its low-single-digit sales growth and flattish margins.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DDS:
